L-Histidine (fermentation-grade pharmaceutical crossover)

Description

Product Overview
L‑Histidine (fermentation‑grade, pharmaceutical crossover) is a high‑quality amino acid produced by controlled microbial fermentation and refined to meet stringent industrial and pharma‑intermediate specifications. It serves as a critical building block in peptide synthesis, buffer formulation, infusion media, and specialty nutrition applications. The product delivers consistent biochemical performance, high purity, and scalability—enabling reliable downstream processing, tighter batch reproducibility, and lower total cost of ownership compared with chemically synthesized alternatives. Strategically, this fermentation‑grade offering bridges industrial robustness with pharmaceutical traceability, making it ideal for contract manufacturers, biotech firms, and formulators who require scalable supply with elevated quality controls. Beta-glucosidase

Key Specifications & Technical Characteristics

• Chemical identity: L‑Histidine monohydrochloride (or L‑Histidine free base—specify variant on PO), CAS number available on request.

• Composition: Predominantly L‑Histidine (> specified purity), minimal residual fermentation by‑products.

• Purity/grade: Fermentation‑grade, pharmaceutical crossover; typical assay ≥ 98.5% (adjustable to customer spec), heavy metals and residual solvents within pharmacopeial limits upon request.

• Physical form: Free‑flowing crystalline powder.

• Color: White to off‑white.

• Particle size: Median particle size tailored to application (standard ~100–300 µm; narrow distributions available on request).

• Bulk density: Typical range 0.45–0.65 g/mL (packed density available on request).

• Solubility: Highly soluble in water; pH of standard aqueous solution documented in technical data sheet.

• Impurities: Controlled amino acid profile, low endotoxin for pharma crossover batches (certificate of analysis provided).

• Microbiology: Standard industrial microbial limits; low microbial/bioburden options and sterilization-ready lots available.

• Packaging options: 25 kg kraft/PE lined paper bags, 500 kg and 1,000 kg flexible intermediate bulk containers (FIBC), and shrink‑wrapped bulk pallets; custom packaging and GMP‑compliant packing available.

• Shelf life: 24 months under recommended storage conditions (cool, dry, <30°C, sealed), accelerated stability data available.

• Documentation: Certificate of Analysis (CoA), Mill Test Report (MTR), SDS, and optional regulatory dossiers for pharma crossover use.

Core Industrial Applications

• Biopharmaceuticals and biotech: Amino acid feedstock for cell culture media, peptide synthesis, and recombinant protein production; improves cell viability and protein yield through consistent nutrient profiles.

• Pharmaceutical manufacturing: Intermediate in formulation and buffer systems where pharmaceutical crossover quality is required for downstream API conversion.

• Specialty nutrition and nutraceuticals: Ingredient in parenteral nutrition, infant formulas, and clinical nutrition products where traceability and impurity control are critical.

• Chemical synthesis and fine chemicals: Building block in synthetic routes and as a chiral auxiliary where high enantiomeric purity reduces downstream purification steps.

• Agrochemicals and animal feed: Nutritional additive for specialized feed formulations, with fermentation provenance preferred for sustainability credentials.
  Why it outperforms alternatives

• Fermentation origin delivers superior stereochemical purity and lower racemization risk than some chemical syntheses.

• Tight impurity control reduces downstream purification burden and increases process yield.

• Custom particle sizing and packing reduce handling losses, dusting, and blending variability—improving operational throughput and reducing QA rejects.

Competitive Advantages

• Quality consistency: ISO‑aligned, GMP‑capable manufacturing with batch‑to‑batch reproducibility and full traceability from fermentation to final packaging.

• Supply reliability: Vertically integrated fermentation base with multi‑site capacity and strategic raw‑material sourcing to mitigate single‑point failures.

• Logistics capability: Export experience, containerized bulk loading, and local distribution channels for time‑sensitive supply chains; documentation and customs support for regulated exports.

• Price competitiveness: Economies of scale combined with fermentation efficiency deliver attractive unit costs for large‑volume buyers while preserving crossover quality.

• Sustainability: Fermentation process with optimized resource use, reduced hazardous reagents versus chemical synthesis, and options for lower carbon footprint sourcing.

• Technical support: Application engineering support, stability and compatibility guidance, and regulatory documentation packages to accelerate qualification and scale‑up.

Commercial & Supply Information

• Minimum order quantity (MOQ): BULK 20 MT.

• Typical lead time: Quoted per order; scalable capacity for recurring contracts and long‑term agreements.

• Loading capacity (MT per container):

  • 20 ft container: up to 20 MT (FIBC/bulk palletized depending on packaging).

  • 40 ft container: up to 24–26 MT (optimized pallet configuration/FIBC).